SCHEMBL20202836

SCHEMBL20202836

CN(C)c1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 8/20 0.81
MEN1 O00255 5/20 0.81
KMT2A Q03164 5/20 0.81
MAPT P10636 4/20 0.81
TDP1 Q9NUW8 4/20 0.81
HPGD P15428 3/20 0.81
HTT P42858 2/20 0.81
RECQL P46063 2/20 0.81
BLM P54132 2/20 0.81
PRMT1 Q99873 2/20 0.81
ACE2 Q9BYF1 2/20 0.81
CYP2C19 P33261 1/20 0.81
SMAD3 P84022 1/20 0.81
LMNA P02545 3/20 0.61
GPR55 Q9Y2T6 2/20 0.61
ALOX12 P18054 2/20 0.61
POLB P06746 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
ALDH1A1 P00352 4/20 0.56
USP2 O75604 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31580046 0.92 FTO (0.66) FTOMEN1KMT2AMAPTTDP1
SCHEMBL9610878 0.92 FTO (0.66) FTOMEN1KMT2AMAPTTDP1
Fluorescein SCHEMBL27818570 0.91 FTO (0.92) FTOMEN1KMT2AMAPTTDP1
SCHEMBL10145542 0.91 FTO (0.77) FTOMEN1KMT2AMAPTTDP1
Fluorescein SCHEMBL8648355 0.90 FTO (0.94) FTOMEN1KMT2AMAPTTDP1
Fluorescein SCHEMBL29371199 0.90 FTO (1.00) FTOMEN1KMT2AMAPTTDP1
Fluorescein SCHEMBL29388667 0.90 FTO (1.00) FTOMEN1KMT2AMAPTTDP1
Fluorescein SCHEMBL30272223 0.90 FTO (1.00) FTOMEN1KMT2AMAPTTDP1
Fluorescein SCHEMBL16533 0.90 FTO (1.00) FTOMEN1KMT2AMAPTTDP1
Fluorescein SCHEMBL3645090 0.90 FTO (1.00) FTOMEN1KMT2AMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10413583-B2 Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods THE UNIVERSITY OF CHICAGO (US) 2019-09-17 US disclosed
US-20180147250-A1 SYNTHETIC SUBSTRATES FOR ENZYMES THAT CATALYZE REACTIONS OF MODIFIED CYSTEINES AND RELATED METHODS THE UNIVERSITY OF CHICAGO 2018-05-31 US disclosed
US-20180147250-A1 SYNTHETIC SUBSTRATES FOR ENZYMES THAT CATALYZE REACTIONS OF MODIFIED CYSTEINES AND RELATED METHODS THE UNIVERSITY OF CHICAGO 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10413583-B2 Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods DNPEP, PTMS, CTH FTO 1145/4885MEN1 1884/4885KMT2A 3156/4885
US-20180147250-A1 SYNTHETIC SUBSTRATES FOR ENZYMES THAT CATALYZE REACTIONS OF MODIFIED CYSTEINES AND RELATED METHODS DNPEP, PTMS, CTH FTO 1145/4885MEN1 1884/4885KMT2A 3156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.